Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Charlotte's Web Holdings Reports Q4-2020 Results

      Charlotte's Web is a certified B Corp and the market leader in hemp CBD wellness products. (CNW Group/Charlotte's Web Holdings, Inc.)

      News provided by

      Charlotte's Web Holdings, Inc.

      Mar 25, 2021, 06:07 ET

      Share this article

      Share this article


      Quarterly growth and market share gains

      BOULDER, Colo., March 25, 2021 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market share leader in full spectrum cannabidiol (CBD) hemp extract wellness products and a certified B Corp, today reported financial results for the fourth quarter and year ended December 31, 2020. All amounts are expressed in United States dollars unless otherwise noted. Certain metrics, including those expressed on an adjusted basis, are non-IFRS measures, see "Non-IFRS Measures" below.

      2020 12-Month Financial Highlights

      • Total net revenue increased to $95.2 million vs. $94.6 million in 2019
      • Direct-to-Consumer ("DTC") eCommerce sales grew 27.6% in 2020 contributing 67.0% of total revenue, substantially offsetting a decline of 29.5% in B2B sales impacted by the COVID-19 pandemic
      • Gross profit, excluding the impact attributable to the inventory provision, of $60.3 million was 63.3% of consolidated revenue
      • Adjusted EBITDA loss was $20.2 million
      • $52.8 million cash and $113.6 million working capital at December 31, 2020

      2020 12-Month Business Highlights

      • Completed acquisition of Abacus Health to become the market share leader in CBD topicals1
      • Invested $28.3 million capex including new facilities to expand capacity for production, extraction, R&D, and distribution
      • Launched CW Labs R&D division to advance hemp science and clinical studies
      • Secured 3 U.S. Patents for the Company's proprietary hemp cultivars bringing total patents to 5 in 2021
      • Increased distribution from 10,000 doors to more than 22,000 unique retail doors
      • Sponsored a third-party liver health study to address FDA need for quantitative data
      • Drove federal and state legislative actions to help develop comprehensive regulatory framework
      • Earned B Corp certification

      Q4-2020 Financial Highlights  

      • Revenue increased 17.9% to $26.9 million vs. Q4-2019 and increased 7.0% vs. Q3-2020
      • DTC sales increased 21.2% year-over-year, contributing $17.4 million or 64.8% of Q4 revenue
      • Net revenue increased quarter-over-quarter for both DTC 4.2% and B2B 12.7%
      • Gross profit, excluding the impact attributable to a Q4 inventory provision, was $16.8 million, or 62.2% of consolidated revenue
      • Adjusted EBITDA loss of $2.1 million vs. loss of $6.7 million in Q3-2020

      Q4-2020 Business Highlights

      • Increased DTC eCommerce transactions, conversion rates, subscriptions and unit volume
      • Commenced Phase III extraction infrastructure and R&D expansion in new 137,000 sq ft facility to build out production capacity ahead of anticipated growth. Related Q4 capex of $5.9 million.
      • Secured 5-year exclusive distribution partnership with Intercare/Canndoc in Israel as first step in international expansion strategy
      • Exited 2020 as market share leader in total food/drug/mass retail ("F/D/M"), US natural specialty retail, and DTC channel

      "We turned a challenging start to 2020 into a strong finish, taking multiple actions and outperforming much of the competitive set to extend our brand and market share leadership," said Deanie Elsner, CEO of Charlotte's Web. "We filled product and channel gaps with competitive offerings and advanced the science of hemp CBD through CW Labs and collaborative studies with top tier institutions. We have now protected our intellectual property with 5 patents awarded for our proprietary cultivars and have defended our trademarked Charlotte's Web™ brand though a recent judgement. In 2021 we are positioning for long-term growth and shareholder value creation as we evolve towards establishing Charlotte's Web as a leading global botanicals wellness company by expanding into cannabis wellness where federally permissible. To support our international growth we have an exclusive agreement with one of Israel's largest medical cannabis producers, and in the U.S. we secured future optionality through a strategic option to acquire Stanley Brothers cannabis business pending US federal legalization of cannabis."

      Q4-2020 Financial Review
      The following table sets forth selected financial information for the periods indicated.



      Three months ended


      Year ended



      December 31,


      December 31,

      U.S. $ millions, except per share data


      2020


      2019


      2020


      2019










      Revenue


      $

      26.9


      $

      22.8


      $

      95.2


      $

      94.6

      Gross profit (loss) before biological assets
      adjustment


      10.6


      (1.7)


      52.3


      50.5

      Net impact, fair value of biological assets


      (0.4)


      0.4


      —


      (0.2)

      Gross profit (loss)


      10.9


      (2.1)


      52.3


      50.6

      Operating expenses


      23.6


      26.4

      —

      104.7


      75.4

      Change in fair value of warrants and other
      expense (income), net


      2.1


      (2.9)


      (11.6)


      (3.6)

      Loss before taxes


      (14.7)


      (25.5)


      (40.9)


      (21.2)

      Net loss and comprehensive loss


      $

      (14.7)


      $

      (18.8)


      $

      (47.2)


      $

      (15.6)

      EPS basic


      $

      (0.11)


      $

      (0.19)


      $

      (0.38)


      $

      (0.16)

      EPS diluted


      $

      (0.11)


      $

      (0.19)


      $

      (0.38)


      $

      (0.16)

      Adjusted EBITDA1


      $

      (2.1)


      $

      (10.1)


      $

      (20.2)


      $

      (1.3)



















      Assets:


      December 31, 2020


      December 31, 2019





      Cash and cash equivalents


      $

      52.8


      $

      68.6





      Total assets


      $

      310.9


      $

      222.9





      Liabilities:









      Long-term liabilities


      $

      27.7


      $

      39.8





      Total liabilities


      $

      56.7


      $

      69.2





      The following information sets forth selected quarterly revenue information for the Company's recent fiscal quarters.

      U.S. $ millions

      Q4

      Q3

      Q2

      Q1

      Q4

      Q3

      Q2

      Q1


      2020

      2020

      2020

      2020

      2019

      2019

      2019

      2019

      Revenue

      $

      26.9

      $

      25.2

      $

      21.7

      $

      21.5

      $

      22.8

      $

      25.1

      $

      25.0

      $

      21.7

      Consolidated fourth quarter revenue increased to $26.9 million, as compared to $22.8 million in 2019, an increase of 17.9% compared to the same period in 2019, and 7.0% compared to the prior three months ended September 30, 2020. During 2020 the Company implemented a competitive pricing realignment strategy across its product portfolio resulting in increased unit sales and expanded market share in the second half offsetting some of the headwinds created by COVID-19.  B2B net sales increased 12.4% year-over-year supported by expanded topical product offerings. DTC net sales grew by 21.2% year-over-year supported by the pricing realignment and higher conversion rates through ongoing marketing and social media programs. Year-over-year new consumer acquisitions increased 52% and conversion rates increased 98%. DTC net revenue accounted for 64.8% of total revenue in the fourth quarter compared to 63.0% for the same period in the prior year.



      Three months ended




      Year ended





      December 31,




      December 31,





      2020


      2019


      % Increase
      (Decrease) of
      Revenue


      2020


      2019


      % Increase
      (Decrease) of
      Revenue















      Revenue - U.S. $ millions


      $

      26.9


      $

      22.8


      17.9

      %


      $

      95.2


      $

      94.6


      0.7

      %















      Direct-to-consumer ("DTC")


      $

      17.4


      $

      14.4

      1

      21.2

      %


      $

      63.8


      $

      50.0

      1

      27.6

      %

      Business-to-business ("B2B")


      $

      9.5


      $

      8.4

      1

      12.4

      %


      $

      31.4


      $

      44.6

      1

      (29.5)

      %



      1

      Revenues for the three months and year ended December 31, 2019 were recategorized to conform with 2020 categorization.

      Gross profit for the fourth quarter was 40.6% compared to (9.0)% last year. Gross profit, excluding the impact attributable to an inventory provision, was 62.2% compared to 52.0% last year.

      Operating expenses were $23.6 million, a 10.4% year-over-year decrease from $26.4 million. High operating expenses reflect the Company's investments in capacity expansion and transition to a consumer-packaged goods ("CPG") operating company capable of supporting mass retail channel growth. In response to lower B2B retail sales growth during the pandemic, in Q4-2020 management took actions to better align operating expenses through an expense optimization program successfully achieving reductions of more than 10% of the consolidated expense run rate by the end of 2020. This was achieved despite the addition of the CW Labs R&D division and the Abacus acquisition during the year. As a percent of revenue operating expenses improved from 136%, to 113% and 88% for Q2, Q3 and Q4, respectively in 2020.

      Adjusted EBITDA for the quarter was negative $2.1 million, or (7.7)% of consolidated revenue, compared to Adjusted EBITDA of negative $10.1 million, or (44.4)% of revenue, for the fourth quarter of 2019. The improved Adjusted EBITDA ratio  reflects higher revenue combined with the expense optimization program.

      Balance Sheet and Cash Flow
      The Company used $5.1 million of cash in operations during the fourth quarter of 2020 compared to $8.6 million of cash used in operations during the fourth quarter of 2019. The Company's cash and working capital at December 31, 2020 were $52.8 million and $113.6 million, respectively, compared to $68.6 million and $116.9 million at December 31, 2019.


      Three months ended


      December 31


      2020


      2019


      $Change


      % Change

      Cash beginning of period

      $65.9


      $35.0


      $30.9


      88.3

      %

      Cash flows from (used in):









      Operating activities

      (5.1)


      (8.6)


      3.5


      (40.7)

      %

      Investing activities

      (7.6)


      (4.9)


      (2.7)


      55.1

      %

      Financing activities

      (0.4)


      47.1


      (47.5)


      (100.8)

      %

      Cash, end of period

      $52.8


      $68.6


      $(15.8)


      (23.0)

      %

      Consolidated Financial Statements and Management's Discussion and Analysis
      The Company's audited consolidated financial statements and accompanying notes for the periods ended December 31, 2020 and 2019, and related management's discussion and analysis of financial condition and results of operations ("MD&A"), are available under the Company's profile on SEDAR at www.sedar.com and on the Investor Relations section of the Company's website at https://investors.charlottesweb.com.

      Conference Call
      Management will host a conference call to discuss the Company's fourth quarter 2020 results at 8:30a.m. ET on Thursday, March 25, 2021. To participate in the call, please dial 1-647-427-7450 or 1-888-231-8191 approximately 10 minutes before the conference call and provide conference ID 7397494. A recording of the call will be available through April 1, 2021. To listen to the rebroadcast please dial 1-416-849-0833 and provide the same conference ID.

      A webcast of the call can be accessed through the investor relations section of the Charlotte's Web website.

      About Charlotte's Web Holdings, Inc.

      Charlotte's Web Holdings, Inc., a Certified B Corporation headquartered in Boulder, Colorado, is the  market leader in the production and distribution of innovative hemp derived cannabidiol ("CBD")  wellness products under a family of brands which includes Charlotte's Web™, CBD Medic™, CBD Clinic™, and Harmony Hemp. The Company's premium quality products start with proprietary hemp genetics that are 100-percent American farm grown and manufactured into whole-plant hemp extracts containing a full spectrum of naturally occurring phytocannabinoids including CBD, CBC, CBG, terpenes, flavonoids and other beneficial hemp compounds.    Charlotte's Web product categories include  CBD oil tinctures (liquid products), CBD gummies (sleep, stress, inflammation recovery), CBD capsules, CBD topical creams and lotions, as well as CBD pet products for dogs. Charlotte's Web is the number one CBD brand in the USA and is distributed through more than 22,000 retail locations, select distributors and online through the Company's website at www.CharlottesWeb.com.  

      Charlotte's Web was founded by the Stanley Brothers with a mission to unleash the healing powers of botanicals through compassion and science, benefiting the planet and all who live upon it.  Charlotte's Web is a socially and environmentally conscious company and is committed to using business as a force for good and a catalyst for innovation. The Company weighs sound business decisions with consideration for how its efforts affect its employees, customers, the environment, and diverse communities. The rate the Company pays for agricultural products reflects a fair and sustainable rate driving higher quality yield, encouraging regenerative farming practices, and supporting U.S. farming communities. Management believes that its socially oriented and environmentally responsible actions have a positive impact on its customers, suppliers, employees and stakeholders. Charlotte's Web donates a portion of its pre-tax earnings to charitable organizations.

      Subscribe to Charlotte's Web investor news.

      Shares of Charlotte's Web trade on the Toronto Stock Exchange (TSX) under the symbol "CWEB" and are quoted in U.S. Dollars in the United States on the OTCQX under the symbol "CWBHF." As of March 22, 2021 Charlotte's Web had 108,912,326 Common Shares outstanding and 77,243.34 Proportional Voting Shares convertible at 400:1 into Common Shares, for an effective equivalent totaling 139,809,661 Common Shares outstanding.

      Non-IFRS Measures

      Adjusted  earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA") is not a recognized performance measure under International Financial Reporting Standards ("IFRS"). Adjusted EBITDA does not have a standardized meaning prescribed by IFRS and therefore may not be comparable to ‎similar measures presented by other issuers. ‎ The term EBITDA consists of net loss and excludes interest ("financing costs"), taxes, depreciation and amortization. Adjusted EBITDA also excludes share-based compensation, impairment of assets, acquisition costs, legal settlement costs, restructuring charges, and adjustments for fair value of biological assets, warrant liabilities, and stock appreciation rights. Adjusted EBITDA is included as a supplemental disclosure because Management believes that such measurement provides a better assessment of the Company's operations on a continuing basis by eliminating certain non-cash charges and charges or gains that are nonrecurring. The most directly comparable measure to Adjusted EBITDA calculated in accordance with IFRS is net loss. See "Adjusted EBITDA" in the MD&A for a reconciliation of Adjusted EBITDA to net loss. 



      Three months ended


      Year ended



      December 31,


      December 31,

      U.S. $ millions


      2020


      2019


      2020


      2019

      Net loss and comprehensive loss


      $

      (14.7)


      $

      (18.8)


      $

      (47.2)


      $

      (15.6)

      Depreciation of property and equipment and
      amortization of intangibles


      3.0


      1.4


      9.8


      4.0

      Financing costs


      0.3


      0.1


      1.3


      0.3

      Interest income


      —


      (0.1)


      (0.2)


      (1.0)

      Income tax expense (benefit)


      —


      (6.7)


      6.3


      (5.6)

      EBITDA


      $

      (11.4)


      $

      (24.1)


      $

      (30.0)


      $

      (17.9)

      Mark-to-market fair value of warrants and stock
      appreciation rights


      1.9


      (2.1)


      (11.4)


      (2.1)

      Fair value changes of biological assets, net


      (0.4)


      0.4


      —


      (0.2)

      Share-based compensation


      1.6


      1.7


      5.9


      3.0

      Impairment of assets


      5.8


      13.9


      8.0


      15.5

      Acquisition costs


      0.2


      —


      3.9


      —

      Legal settlement


      —


      —


      2.1


      —

      Restructuring charges


      0.2


      0.1


      1.3


      0.4

      Adjusted EBITDA1


      $

      (2.1)


      $

      (10.1)


      $

      (20.2)


      $

      (1.3)



      1

      Adjusted EBITDA presented in prior periods has been reclassified to conform with the current period presentation to include Interest income as a reduction of EBITDA and Adjusted EBITDA.  

      Forward-Looking Statements
      In the interest of providing the shareholders and potential investors of Charlotte's Web Holdings, Inc. with information about the Company, including management's assessment of the Company's future plans and operations, certain information provided in this press release constitutes forward-looking statements or information (collectively, "forward-looking statements"). Forward-looking statements are typically identified by words such as "may", "will", "should", "could", "anticipate", "expect", "project", "estimate", "forecast", "plan", "intend", "target", "believe" and similar words suggesting future outcomes or statements regarding an outlook. Although these forward-looking statements are based on assumptions the Company considers to be reasonable based on the information available on the date such statements are made, such statements are not guarantees of future performance and readers are cautioned against placing undue reliance on forward-looking statements. By their nature, these statements involve a variety of assumptions, known and unknown risks and uncertainties, and other factors which may cause actual results, levels of activity, and achievements to differ materially from those expressed or implied by such statements. The forward-looking statements contained in this press release are based on certain assumptions and analysis by management of the Company ("Management") in light of its experience and perception of historical trends, current conditions and expected future development and other factors that it believes are appropriate.

      Forward-looking statements are not historical facts but instead represent management's expectations, estimates and projections regarding the future of our business, future plans, strategies, projections, anticipated events and trends, the economy and other future conditions. Although the Company believes there is a reasonable basis for the expectations and assumptions reflected on the forward-looking statements, undue reliance should not be placed on the forward-looking statements because the Company can give no assurances that they will prove to be correct. The forward-looking statements contained in this press release speak only as of the date hereof and are expressly qualified by this cautionary statement.

      Specifically, this news release contains forward-looking statements relating to, but not limited to: potential capacity expansion for production, extraction, R&D and distribution; international expansion activities and strategy; capacity expansion and transition to a CPG operating company capable of supporting mass retail channel growth; the impact of certain activities on the Company's business and financial condition; suggested regulatory developments; the Company's anticipated trajectory, long-term growth expectations and shareholder value creation; and product expansion, including into cannabis wellness where federally permissible.

      The material factors and assumptions used to develop the forward-looking statements herein include, but are not limited to, the following: (i) the impact of the COVID-19 pandemic; (ii) the regulatory climate in which the Company operates; (iii) the continued sales success of the Company's products; (iv) the continued success of sales and marketing activities; (v) the Company's ability to complete the conversion or buildout of its facilities on time and on budget; (vi) there will be no significant delays in the development and commercialization of the Company's products; (vii) the Company will continue to maintain sufficient and effective production and research and development capabilities to compete on the attributes and cost of its products; (viii) the Company's ability to deal with adverse growing conditions (due to pests, disease, fungus, climate or other factors) in a timely and cost-effective manner; (ix) there will be no significant reduction in the availability of qualified and cost-effective human resources; * new products will continue to be added to the Company's portfolio; (xi) demand for hemp-based wellness products will continue to grow in the foreseeable future; (xii) there will be no significant barriers to the acceptance of the Company's products in the market; (xiii) the Company will be able to maintain compliance with applicable contractual and regulatory obligations and requirements; (xiv) there will be adequate liquidity available to the Company to carry out its operations; and (xv) products do not develop that would render the Company's current and future product offerings undesirable and the Company is otherwise able to minimize the impact of competition and keep pace with changing consumer preferences; and (xvi) the Company will be able to successfully manage and integrate acquisitions and take advantage of synergies from acquisitions.

      The Company's forward-looking statements are subject to risks and uncertainties pertaining to, among other things, the adverse impact of the COVID-19 pandemic to the Company's operations, supply chain, distribution chain, and to the broader market for the Company's products, revenue fluctuations, nature of government regulations (both domestic and foreign), economic conditions, loss of key customers, retention and availability of executive talent, competing products, common share price volatility, loss of proprietary information, product acceptance, internet and system infrastructure functionality, information technology security, cash available to fund operations, crop risk, availability of capital, international and political considerations, the successful integration of acquired businesses, and including but not limited to those risks and uncertainties discussed in the Company's other filings with securities regulators. The impact of any one risk, uncertainty, or factor on a particular forward-looking statement is not determinable with certainty as these are interdependent, and the Company's future course of action depends on Management's assessment of all information available at the relevant time. Except to the extent required by law, the Company assumes no obligation to publicly update or revise any forward-looking statements made in this press release, whether as a result of new information, future events, or otherwise. All subsequent forward-looking statements, whether written or oral, attributable to the Company or persons acting on the Company's behalf, are expressly qualified in their entirety by these cautionary statements.

      These foregoing lists are not exhaustive. Additional information on these and other factors which could affect the Company's operations or financial results are included in the Company's most recent annual information form and other public documents  on file with the Canadian Securities regulatory authorities on www.sedar.com.

      The above summary of assumptions and risks related to forward-looking statements in this news release has been provided in order to provide shareholders and potential investors with a more complete perspective on the Company's current and future operations and such information may not be appropriate for other purposes. There is no representation by the Company that actual results achieved will be the same in whole or in part as those referenced in the forward-looking statements and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by applicable securities law.

      CHARLOTTE'S WEB HOLDINGS, INC.

      CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

      (In thousands of United States dollars)








      December 31, 2020

      December 31, 2019

      ASSETS






      Current assets:



      Cash

      $

      52,803

      $

      68,553

      Trade and other receivables, net

      6,274

      5,462

      Note receivable

      1,753

      1,421

      Note receivable - related party

      1,004

      —

      Inventories

      61,936

      64,054

      Prepaid expenses and other current assets

      7,390

      3,592

      Income taxes receivable

      11,440

      3,273


      142,600

      146,355

      Non-current assets:



      Property and equipment, net

      60,269

      42,949

      Intangible assets, net

      25,376

      1,596

      Goodwill

      77,454

      —

      Deferred tax assets

      4

      30,417

      Other long-term assets

      5,178

      1,625


      $

      310,881

      $

      222,942




      LIABILITIES AND SHAREHOLDERS' EQUITY






      Current liabilities:



      Accounts payable

      $

      4,891

      $

      8,798

      Accrued liabilities

      11,519

      7,323

      Deferred revenue

      615

      550

      Current cultivation liabilities

      9,304

      10,803

      Current notes payable

      629

      9

      Current lease obligations

      2,015

      1,945


      28,973

      29,428

      Non-current liabilities:



      Long-term cultivation liabilities

      2,513

      14,289

      Long-term notes payable

      144

      3

      Long-term lease obligations

      20,567

      22,116

      Warrant liabilities

      4,304

      3,408

      Other long-term liabilities

      151

      —


      56,652

      69,244

      Shareholders' equity:



      Share capital

      279,308

      123,927

      Contributed surplus

      19,849

      27,513

      (Accumulated deficit) Retained earnings

      (44,928)

      2,258


      $

      310,881

      $

      222,942

      CHARLOTTE'S WEB HOLDINGS, INC.

      CONSOLIDATED STATEMENTS OF LOSS AND OTHER COMPREHENSIVE LOSS

      (In thousands of United States dollars, except per share amounts)












      Three months ended

      Year ended


      December 31,

      December 31,


      2020

      2019

      2020

      2019






      Revenue

      $

      26,927

      $

      22,830

      $

      95,226

      $

      94,594

      Cost of sales

      16,364

      24,532

      42,937

      44,144

      Gross profit before (gain) loss on fair value of biological
      assets

      10,563

      (1,702)

      52,289

      50,450

      Realized fair value (gain) included in inventory sold

      (203)

      (432)

      (289)

      (994)

      Unrealized fair value loss on growth of biological assets

      (178)

      794

      323

      842

      Gross profit

      10,944

      (2,064)

      52,255

      50,602






      Expenses:





      General and administrative

      13,809

      14,961

      68,764

      45,546

      Sales and marketing

      8,131

      10,739

      30,010

      28,107

      Research and development

      1,668

      655

      5,951

      1,754

      Operating expenses

      23,608

      26,355

      104,725

      75,407

      Operating loss

      (12,664)

      (28,419)

      (52,470)

      (24,805)

      Financing costs

      357

      85

      1,260

      326

      Interest income

      (6)

      (141)

      (185)

      (994)

      Change in fair value of warrants and other income, net

      1,716

      (2,869)

      (12,671)

      (2,928)

      Loss before taxes

      (14,731)

      (25,494)

      (40,874)

      (21,209)

      Income tax expense (benefit)

      (13)

      (6,716)

      6,312

      (5,642)

      Net loss and comprehensive loss

      $

      (14,718)

      $

      (18,778)

      $

      (47,186)

      $

      (15,567)






      Weighted average number of common shares - basic

      139,230,803

      100,380,496

      125,012,249

      96,539,194

      Weighted average number of common shares - diluted

      139,230,803

      100,380,496

      125,012,249

      96,539,194






      Loss earnings per share - basic

      $

      (0.11)

      $

      (0.19)

      $

      (0.38)

      $

      (0.16)

      Loss earnings per share - diluted

      $

      (0.11)

      $

      (0.19)

      $

      (0.38)

      $

      (0.16)


      CHARLOTTE'S WEB HOLDINGS, INC.

      CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

      (In thousands of United States dollars)











      Year ended December 31, 2019

      Share capital

      Contributed
      surplus

      Retained
      earnings

      Total

      Balance - December 31, 2018

      $

      78,316

      $

      25,357

      $

      17,825

      $

      121,498

      Exercise of common stock options

      2,850

      (1,264)

      —

      1,586

      Exercise of common stock warrants

      1,328

      (842)

      —

      486

      Accumulated effect of income tax from stock options

      —

      1,284

      —

      1,284

      Share-based compensation expense

      —

      2,978

      —

      2,978

      2019 Share offering, net of warrants

      44,295

      —

      —

      44,295

      Share issuance costs

      (2,862)



      (2,862)

      Net loss and comprehensive loss

      —

      —

      (15,567)

      (15,567)

      Balance - December 31, 2019

      $

      123,927

      $

      27,513

      $

      2,258

      $

      153,698






      Year ended December 31, 2020

      Share capital

      Contributed
      surplus

      Accumulated
      deficit

      Total

      Balance - December 31, 2019

      $

      123,927

      $

      27,513

      $

      2,258

      $

      153,698

      Exercise of common stock options

      4,001

      (1,534)

      —

      2,467

      Withholding of common stock upon vesting of restricted share
      awards

      1,328

      (1,347)

      —

      (19)

      Accumulated effect of income tax from stock options

      —

      (16,087)

      —

      (16,087)

      Share-based compensation expense

      —

      5,897

      —

      5,897

      2020 Share Offering, net of warrants

      47,959

      —

      —

      47,959

      Share issuance costs

      (3,368)

      —

      —

      (3,368)

      Abacus Acquisition

      105,461

      5,407

      —

      110,868

      Net loss and comprehensive loss

      —

      —

      (47,186)

      (47,186)

      Balance - December 31, 2020

      $

      279,308

      $

      19,849

      $

      (44,928)

      $

      254,229


      CHARLOTTE'S WEB HOLDINGS, INC.

      CONSOLIDATED STATEMENTS OF CASH FLOWS

      (In thousands of United States dollars)





      Year ended December 31,


      2020

      2019




      Cash flows from operating activities:



      Net loss

      $

      (47,186)

      $

      (15,567)

      Items not involving cash:



      Depreciation

      7,746

      3,666

      Amortization

      2,008

      300

      Change in fair value of biological assets

      34

      (152)

      Change in fair value of warrant liabilities

      (11,167)

      (2,107)

      Expected credit losses

      834

      422

      Inventory provision, net

      8,025

      15,474

      Share-based compensation

      5,897

      2,978

      Loss on disposal of assets

      (5)

      18

      Deferred income taxes

      14,348

      (5,684)




      Changes in working capital:



      Trade and other receivables, net

      2,276

      (1,010)

      Inventories

      (1,782)

      (53,498)

      Prepaid expenses and other current assets

      (3,673)

      325

      Accounts payable

      (8,594)

      3,460

      Accrued liabilities

      829

      840

      Income taxes

      (8,132)

      (1,486)

      Cultivation liabilities

      (11,289)

      18,275

      Other operating assets and liabilities, net

      1,239

      270


      (48,592)

      (33,476)




      Cash flows from investing activities:



      Cash acquired in business combinations

      11,181

      —

      Purchases of property and equipment

      (25,904)

      (13,775)

      Purchases of intangible assets

      (2,353)

      (1,278)

      Proceeds from sale of assets

      91

      54

      Funding of note receivable

      (1,400)

      (1,400)

      Collections on note receivable

      1,125

      —

      Funding of note receivable - related party

      (1,000)

      —

      Proceeds from loans due from related parties

      —

      128

      Other investing activities

      (1,181)

      (1,444)


      (19,441)

      (17,715)




      Cash flows from financing activities:



      Proceeds from public offering

      57,165

      49,810

      Proceeds from common stock option exercises

      2,467

      1,586

      Withholding of common stock upon vesting of restricted share awards

      (19)

      —

      Proceeds from common stock warrant exercises

      —

      486

      Payments on notes payable

      (809)

      (9)

      Payments on lease obligations

      (3,153)

      (2,671)

      Share issuance costs

      (3,368)

      (2,862)


      52,283

      46,340







      Decrease in cash and cash equivalents

      (15,750)

      (4,851)

      Cash and cash equivalents, beginning of year

      68,553

      73,404

      Cash and cash equivalents, end of period

      $

      52,803

      $

      68,553






      Supplemental disclosures of cash flows from operating activities:





      Cash paid for interest

      $

      (145)

      $

      (45)

      Cash paid for interest on lease obligations


      (1,115)


      (281)

      Cash received from interest


      185


      994

      Cash received (paid) for taxes


      14


      (1,765)

      Non-cash purchases of property and equipment


      (1,291)


      (1,932)

      Non-cash purchases of intangibles


      (35)


      —

      Non-cash inventory provision


      (2,073)


      —


      SOURCE Charlotte's Web Holdings, Inc.

      Modal title

      Also from this source

      Charlotte's Web Reports 2025 Fourth Quarter and Full Year Financial Results

      Charlotte's Web Reports 2025 Fourth Quarter and Full Year Financial Results

      Anticipated CMMI Medicare Pilot Program Participation, Regulatory Momentum, and Cost Structure Improvements Position Company for Growth and Pathway...

      Charlotte's Web Announces Transaction with BAT: Debenture Conversion and US$10M Equity Investment to Strengthen Balance Sheet

      Charlotte's Web Announces Transaction with BAT: Debenture Conversion and US$10M Equity Investment to Strengthen Balance Sheet

      Transaction Addresses Capital Structure and Supports Near-Term Operating Priorities, Including Anticipated CMMI Medicare Pilot Program Participation...

      More Releases From This Source

      Explore

      Cannabis

      Cannabis

      Earnings

      Earnings

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.